H1° histone and differentiation of dendritic cells. A molecular target for tumor-derived factors

Journal of Leukocyte Biology

Volumn 72, Issue 2, 2002, Pages 285-296

  Gabrilovich, Dmitry I ^a   Cheng, Pingyan ^a   Fan, Yuhong ^a,b   Yu, Bin ^a   Nikitina, Ekaterina ^a   Sirotkin, Allen ^a,b   Shurin, Michael ^a,c   Oyama, Tsunehiro ^a,d   Adachi, Yasushi ^a,d   Nadaf, Sorena ^a,d   Carbone, David P ^a,d   Skoultchi, Arthur I ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Cellular differentiation; Monocytes macrophages; Tumor immunity

Indexed keywords

ANTIGEN; HISTONE H1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR PROTEIN; BIOLOGICAL FACTOR; CYTOKINE; ENDOTHELIAL CELL GROWTH FACTOR; FLT3 LIGAND PROTEIN; HISTONE; LYMPHOKINE; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE CONTROL; GRANULOCYTE FUNCTION; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR ESCAPE; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL STRAIN 3T3; CLONOGENIC ASSAY; CULTURE MEDIUM; CYTOLOGY; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOSURVEILLANCE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; SECRETION;

ANIMALIA;

3T3 CELLS; ANIMALS; BIOLOGICAL FACTORS; CELL DIFFERENTIATION; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HISTONES; IMMUNOLOGIC SURVEILLANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOKINES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; MYELOID CELLS; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; PHAGOCYTOSIS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036667326     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Enk, A. H., Jonuleit, H., Saloga, J., Knop, J. (1997) Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Intern. J. Cancer 73, 309-316.
2. Nestle, F. O., Burg, G., Fah, J., Wrone-Smith, T., Nickoloff, B. J. (1997) Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am. J. Pathol. 150, 641-651.
3. Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., Carbone, D. P. (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3, 483-490.
4. Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., Blay, J. Y. (1998) Inhibition of the differentiation of dendritic cells from CD34(4+) progenitors by tumor cells: role of interleukin-6 and macrophage-colony-stimulating factor. Blood 92, 4778-4791.
5. Almand, B., Resser, J. R., Lindman, B., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., Gabrilovich, D. I. (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin. Cancer Res. 6, 1755-1766.
6. Almand, B., Clark, J. I., Nikitina, E., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients. A mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689.
7. Gabrilovich, D. I., Velders, M., Sotomayor, E., Kast, W. M. (2001) Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166, 5398-5406.
8. Wolffe, A. P., Khochbin, S., Dimitrov, S. (1997) What do linker histone do in chromatin? BioEssays 19, 249-255.
9. Steinbach, O. C.,. Wolffe, A. P., Rupp, R. A. W. (1997) Somatic linker histones cause loss of mesodermal competence in Xenopus. Nature 389, 395-399.
10. Croston, G. E., Kerrigsan, L. A., Kira, L. M., Marshak, D. R., Kadonaga, J. T. (1991) Sequence-specific antirepression of histone H1-mediated inhibition of basal RNA polymerase II transcription. Science 251, 643-649.
11. Shen, X., Gorovsky, M. A. (1996) Linker histone regulates specific gene expression but not global transcription in vivo. Cell 86, 475-483.
12. Mistell, T., Gunjan, A., Hock, R., Bustin, M., Brown, D. T. (2000) Dynamic binding of histone H1 to chromatin in living cells. Nature 408, 877-881.
13. Doenecke, D., Albig, W., Bouterfa, H., Drabent, B. (1994) Organization and expression of H1 histone and H1 replacement genes. J. Cell. Biochem. 54, 423-431.
14. Wang, Z-F., Sirotkin, A. M., Buchold, G., Skoultchi, A. I., Marzuff, W. F. (1997) The mouse histone H1 genes: gene organization and differential regulation. J. Mol. Biol. 271, 124-138.
15. Harris, M. E., Bohni, R., Schneiderman, M. H., Ramamurthy, L., Schumperli, D., Marzluff, W. H. (1991) Regulation of histone mRNA in the unperturbed cell cycle: evidence suggesting control at two post-transcriptional steps. Mol. Cell. Biol. 11, 2416-2424.
16. Lennox, R. W., Cohen, L. H. (1983) The histone H1 complements of dividing and nondividing cells of the mouse. J. Biol. Chem. 258, 262-268.
17. Sirotkin, A., Edelmann, W., Cheng, G., Klein-Szanto, A., Kucherlap, R., Skoultchi, A. I. (1995) Mice develop normally without the H1° linker histone. Proc. Natl. Acad. Sci. USA 92, 6434-6438.
18. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. M., Kast, W. M. (1993) Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23, 2242-2249.
19. Feltkamp, M. C. W., Vreugdenhil, G. R., Vierboom, M. P. M., Ras, E., van der Burg, S. H., ter Schegget, J. Melief, C. J. M., Kast, W. M. (1995) Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur. J. Immunol. 25, 2638-2642.
20. Baarsch, M. J., Wannemuehler, M. J., Molitor, T. W., Murtaugh, M. P. (1991) Detection of tumor necrosis factor a from porcine alveolar macrophages using an L929 fibroblast bioassay. J. Immunol. Methods 140, 15-22.
21. Gabrilovich, D. I., Nadaf, S., Corak, J., Berzofsky, J. A., Carbone, D. P. (1996) Dendritic cells in anti-tumor immune responses. Il. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell. Immunol. 170, 111-120.
22. Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D., Gabrilovich, D. I. (1998) Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hematopoietic progenitor cells. J. Immunol. 160, 1224-1232.
23. Shurin, G., Aalamian, M., Pirtskhalaishvili, G., Bykovskaia, S., Huland, E., Huland, H., Shurin, M. R. (2001) Human prostate cancer blocks the generation of dendritic cells from cd34+ hematopoietic progenitors. Eur. Urol. 39 (Suppl. 4), 37-40.
24. Shurin, G., Shurin, M., Bykovskaia, S., Shogan, J., Lotze, M., Barksdale, E. J. (2001.) Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res. 61, 363-369.
25. Gabrilovich, D., Ciemik, F., Carbone, D. P. (1996) Dendritic cells in anti-tumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell. Immunol. 170, 101-110.
26. Gabrilovich, D. I., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., Carbone, D. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92, 4150-4166.
27. Saito, H., Tsujitani, S., Ikeguchi, M., Maeta, M., Kaibara, N. (1998) Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br. J. Cancer 78, 1573-1577.
28. Liang, P., Pardee, A. B. (1997) Differential display methods and protocols. In Methods in Molecular Biology, vol. 85, New York, Humana, 306.
29. Carrasco, D., Ryseck, R-P., Bravo, R. (1993) Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118, 1221-1231.
30. Burkly, L., Hession, C., Ogata, L., Relly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R., Lo, D. (1995) Expression of relB is required for development of thymic medulla and dendritic cells. Nature 373, 531-536.
31. Ghosh, S., May, M. J., Kopp, E. B, (1998) NF-κB and rel proteins. Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
32. Pulendran, B., Lingappa, J., Kennedy, M. K., Smith, J., Teepe, M., Rudensky, A., Maliszewski, C. R., Maraskovsky, E. (1997) Developmental pathways of dendritic cells in vivo. Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159, 2222-2231.
33. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., McKenna, H. J. (1996) Dramatic increase in the numbers of functionally mature dendritic cells in FLT3 ligand-treated mice: multiple dendritic cells subpopulations identified. J. Exp. Med. 184, 1953-1961.
34. Ohm, J. E., Shurin, M. R., Esche, C., Lotze, M. T., Carbone, D. P., Gabrilovich, D. I. (1999) Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo. J. Immunol. 163, 3260-3268.
35. Vremec, D., Shortman, K. (1997) Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, pleen, and lymph nodes. J. Immunol. 159, 565-573.
36. Rousseau, D., Khochbin, S., Gorka, C., Lawrence, J. J. (1991) Regulation of histone H1° accumulation during induced differentiation of murine erythroleukemia cells. J. Mol. Biol. 217, 85-92.
37. Zlatanova, J., Doenecke, D. (1994) Histone H1°: a major player in cell differentiation? FASEB J. 8, 1260-1268.
38. Scatturo, M., Cestelli, A., Casrtiglia, D., Nastasi, T., Di Liegro, I. (1995) Posttranscriptional regulation of H1 zero and H3.3B histones in differentiating rat cortical neurons. Neurochem. Res. 20, 969-976.
39. Tsapali, D. S., Sekeri-Pataryas, K. E., Prombona, A., Sourlingas, T. G. (2000) mRNA levels of the linker histone variant, H1°, in mitotically active human diploid fibroblasts as a function of the phases of the cell cycle and cumulative population doublings. Mech. Aging Dev. 121, 101-112.
40. Flickinger, R. A. (1999) Histone H1° ribosomal RNA synthesis and cell differentiation. J. Theor. Biol. 196, 521-525.